Often dismissed as just another common cold, RSV can be deadly, especially for infants and older people. Hannah and her twin ...

RSV infects almost every child before they turn 2, and kills more than 100,000 infants worldwide each year. Machine learning ...

Hutton DW, Prosser LA, Rose AM, et al. Cost-effectiveness of vaccinating adults aged 60 years and older against respiratory syncytial virus. Vaccine . 2024;42(24):126294. doi:10.1016/j.vaccine ...

Arexvy is approved for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older and in individuals 50 through ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

This summer, GSK cut its yearly vaccine sales projection on the back of a narrowed recommendation for adult respiratory syncytial virus (RSV) vaccines from the Centers for Disease Control and ...

Nearly 5,000 people in Jersey are eligible for the new Respiratory Syncytial Virus (RSV) vaccine which is being rolled out on the island from today. RSV can cause lung infections including ...

Pregnant women across Australia could be offered a free vaccine to protect their babies against respiratory syncytial virus (RSV) from next year. Health Minister Mark Butler has flagged the ...

Covid-19 levels in the United States are high and rising, flu season is approaching quickly, and RSV cases are already ... ahead of the respiratory virus season.” We don’t know how effective ...

“RSV has been the main reason for hospitalisation for children under one year, and it’s a truly frightening disease. “The main reason for the vaccine was to avoid babies landing in ...